Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001424884-09-000033
Filing Date
2009-05-08
Accepted
2009-05-08 16:29:17
Documents
7
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K form10-k.htm 10-K 1550179
2 CHARTERED ACCOUNTANTS GRAPHIC form10-k0.jpg GRAPHIC 10739
3 CHARTERED ACCOUNTANTS CONTACT INFORMATION form10-k1.jpg GRAPHIC 10565
4 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO SECURITIES EXCHANGE ACT exhibit31-1.htm EX-31.1 15890
5 CERTIFICATION OF ACTING PRINCIPAL ACCOUNTING OFFICER PURSUANT TO SECURITIES EXCH exhibit31-2.htm EX-31.2 15620
6 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350 exhibit32-1.htm EX-32.1 5702
7 CERTIFICATION OF ACTING PRINCIPAL ACCOUNTING OFFICER PURSUANT TO 18 U.S.C. SECTI exhibit32-2.htm EX-32.2 5606
  Complete submission text file 0001424884-09-000033.txt   1624271
Mailing Address UNIT 2 - 3590 WEST 41ST AVENUE VANCOUVER A1 V6N 3E6
Business Address UNIT 2 - 3590 WEST 41ST AVENUE VANCOUVER A1 V6N 3E6 604-264-8274
TAPIMMUNE INC (Filer) CIK: 0001094038 (see all company filings)

EIN.: 880277072 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-27239 | Film No.: 09811166
SIC: 2834 Pharmaceutical Preparations